Biblio

54 Ergebnisse exportiert:
Autor Titel Typ [ Jahr(Asc)]
Filterkriterien: Anfangsbuchstabe Des Nachnamens is K  [Alle Filter deaktivieren]
2021
Koistinen H, Künnapuu J, Jeltsch M. KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?. International Journal of Molecular Sciences [Internet]. 2021;22(24):13545. https://www.mdpi.com/1422-0067/22/24/13545PDF Icon Koistinen et al. - 2021 - KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not? (1.28 MB)
Koistinen H, Künnapuu J, Jeltsch M. KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?. International Journal of Molecular Sciences [Internet]. 2021;22(24):13545. https://www.mdpi.com/1422-0067/22/24/13545PDF Icon Koistinen et al. - 2021 - KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not? (1.28 MB)
Künnapuu J, Jeltsch M. Outside in and brakes off for lymphatic growth. Science Signaling [Internet]. 2021;14(695). https://www.science.org/doi/10.1126/scisignal.abj5058PDF Icon Künnapuu and Jeltsch - 2021 - Outside in and brakes off for lymphatic growth (268.05 KB)
Künnapuu J, Bokharaie H, Jeltsch M. Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs. Biology [Internet]. 2021;10(2):167. https://www.mdpi.com/2079-7737/10/2/167PDF Icon Künnapuu et al. - 2021 - Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential [...] (3.44 MB)
2013
Krebs R, Jeltsch M. Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Lymphologie in Forschung und Praxis. 2013;17(1):30-37.
Krebs R, Jeltsch M. Die lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseases of the lymphatic system. [bilingual: English, German]. Lymphologie in Forschung und Praxis [Internet]. 2013;17(2):96 - 104. http://jeltsch.org/sites/jeltsch.org/files/JeltschMichael_Lymphforsch2013_96.pdfPDF Icon Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseas... (3.88 MB)PDF Icon Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 2. Die Rolle von VEGF-C und VEGF-D bei ... (2.6 MB)
Krebs R, Jeltsch M. The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: Basic principles and embryonic development. [bilingual: English, German]. Lymphologie in Forschung und Praxis [Internet]. 2013;17(1):30 - 37. http://jeltsch.org/sites/jeltsch.org/files/JeltschMichael_Lymphforsch2013_30.pdfPDF Icon Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 1: Fundamentals and embryonic development. (2.08 MB)PDF Icon Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 1. Grundlagen und Embryonalentwicklung. (1.82 MB)
2010
Tvorogov D, Anisimov A, Zheng W, Leppänen V-M, Tammela T, Laurinavicius S, u. a.. Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell [Internet]. 2010;18(6):630 - 40. http://view.ncbi.nlm.nih.gov/pubmed/21130043PDF Icon Denis Tvorogov et al., Cancer Cell 2010 (1.3 MB)PDF Icon Denis Tvorogov et al., Cancer Cell 2010, supplement (828.69 KB)
Leppänen V-M, Prota AE, Jeltsch M, Anisimov A, Kalkkinen N, Strandin T, u. a.. Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2010;107(6):2425 - 30. http://view.ncbi.nlm.nih.gov/pubmed/20145116PDF Icon Veli-Matti Leppänen et al. PNAS 2010 (1 MB)PDF Icon Veli-Matti Leppänen et al. PNAS 2010, supporting information (2.23 MB)
Albrecht I, Kopfstein L, Strittmatter K, Schomber T, Falkevall A, Hagberg CE, u. a.. Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis. PLoS ONE [Internet]. 2010;5(11):e14109. http://view.ncbi.nlm.nih.gov/pubmed/21124841PDF Icon Imke Albrecht et al., PLoS One 2010 (3.37 MB)
Bry M, Kivelä R, Holopainen T, Anisimov A, Tammela T, Soronen J, u. a.. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation [Internet]. 2010;122(17):1725 - 33. http://view.ncbi.nlm.nih.gov/pubmed/20937974PDF Icon Maija Bry et al., Circulation 2010 (2.23 MB)PDF Icon Maija Bry et al., Circulation 2010, supplement (17.77 MB)
Bry M, Kivelä R, Holopainen T, Anisimov A, Tammela T, Soronen J, u. a.. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation [Internet]. 2010;122(17):1725 - 33. http://view.ncbi.nlm.nih.gov/pubmed/20937974PDF Icon Maija Bry et al., Circulation 2010 (2.23 MB)PDF Icon Maija Bry et al., Circulation 2010, supplement (17.77 MB)
Bry M, Kivelä R, Holopainen T, Anisimov A, Tammela T, Soronen J, u. a.. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation [Internet]. 2010;122(17):1725 - 33. http://view.ncbi.nlm.nih.gov/pubmed/20937974PDF Icon Maija Bry et al., Circulation 2010 (2.23 MB)PDF Icon Maija Bry et al., Circulation 2010, supplement (17.77 MB)

Seiten